In this op-ed, Scott Mazza of Vitality CBD examines Canada’s cannabis legalization missteps to outline practical lessons for New York as it rolls out adult-use sales. Drawing on Canada’s experience with overproduction, overregulation, and persistent illicit markets, Mazza argues that balanced supply, flexible regulation, and meaningful inclusion of legacy operators are essential to building a sustainable, competitive legal cannabis market in New York.

In this guest column, Scott Mazza, co-founder and COO of Vitality CBD, outlines three key policy changes he believes should be addressed in the 2023 Farm Bill to bring clarity and stability to the CBD market. Mazza argues for FDA approval of CBD as a dietary supplement, clear federal treatment of Delta-8 THC, and a revised THC threshold for hemp, positioning regulatory certainty as essential for consumer safety, product quality, and long-term industry growth.

In this in-depth product review, It’s Free At Last highlights Vitality CBD as a wellness brand focused on sleep support, stress relief, and clean formulation standards. The article details Vitality CBD’s USDA-certified organic oils and full-spectrum salves, emphasizing third-party lab testing, organic sourcing, and transparent cannabinoid content as differentiators for consumers seeking safe, effective alternatives to traditional sleep and anxiety aids.

In this curated self-care and wellness guide, Posh Beauty Blog features Vitality CBD Salve as a premium topical option, highlighting its organic ingredients, USDA Organic certification, and third-party lab testing. The article positions Vitality CBD as a clean, trustworthy choice within a broader lifestyle and beauty context, emphasizing product purity, potency, and safety for consumers seeking high-quality CBD solutions as part of their everyday wellness routines.

In this guest column, Scott Mazza, co-founder and COO of Vitality CBD, examines what current research does—and does not—tell us about CBD salves for pain management and athletic recovery. Mazza outlines the compound’s anti-inflammatory potential, growing adoption among professional athletes, and the need for stronger clinical evidence and product standards, emphasizing third-party testing and quality controls as essential safeguards as interest in CBD-based alternatives to opioids continues to grow.

In this op-ed, Scott Mazza, co-founder and COO of Vitality CBD, argues that continued FDA inaction on approving CBD as a dietary supplement is putting consumers at risk and undermining industry credibility. Mazza explains how the lack of federal standards enables unsafe products and misleading claims, and calls for clear regulatory approval to legitimize CBD, protect consumers, and support evidence-based research and responsible manufacturers.

In this guest column, Scott Mazza of Vitality CBD examines the growing acceptance of CBD in professional sports following Major League Baseball’s decision to allow CBD sponsorships. Drawing on developments across the MLB, NFL, and UFC, Mazza explains why CBD aligns with athlete recovery and consumer awareness, while outlining the regulatory and advertising constraints companies must navigate as CBD enters mainstream sports media.

The Buffalo News covers the early scramble among small businesses to enter New York’s legal cannabis market. Scott Mazza of Vitality CBD shares insights on regulatory uncertainty and retail positioning, reinforcing the brand’s presence at the forefront of local cannabis entrepreneurship.

In this guest column, Scott Mazza of Vitality CBD explains why organic cultivation and extraction standards are critical to ensuring safe, high-quality CBD products. Drawing on research and industry testing data, Mazza details how pesticides, heavy metals, and poor extraction methods compromise product integrity, and outlines why USDA organic certification and third-party lab testing are essential safeguards for consumers seeking clean, accurately labeled hemp-derived CBD.

In this opinion piece, Scott Mazza, co-founder and COO of Vitality CBD, calls attention to widespread quality and compliance failures in New York’s CBD market, citing inaccurate labeling, contamination risks, and weak enforcement. Drawing on regulatory developments and industry investigations, Mazza urges stronger oversight alongside informed consumer pressure, arguing that transparent third-party testing and accountability are essential to protecting consumers and restoring trust in hemp-derived CBD products.

In this guest column, Scott Mazza, co-founder and COO of Vitality CBD, calls for stricter enforcement of third-party lab testing and quality controls in New York’s hemp-derived CBD market. Drawing on industry data and investigative findings, Mazza explains how weak compliance around potency, purity, and labeling puts consumers at risk, and argues that transparent testing, consumer pressure, and producer-led standards are essential to restoring trust and accountability in the state’s CBD ecosystem.

In this feature exploring the intersection of artificial intelligence, sports rehabilitation, and cannabinoids, Scott Mazza, co-founder and COO of Vitality CBD, examines how AI and machine learning could accelerate clinical understanding of CBD’s role in pain management and recovery. Drawing on emerging research, league-funded studies, and regulatory shifts, the article positions data-driven analysis as essential for moving CBD from anecdotal use toward evidence-based applications in athletics and healthcare.